ivan health semaglutide obesitymedicine #metabolichealth #glp1ra #semaglutide |

With innovative drug delivery systems on the horizon, the potential of GLP-1RAs in optometry is only expected to rise

Nausea, vomiting, diarrhea, and other gastrointestinal distress are potential side effects of this weight loss medication

For many patients this helps reduce "food noise," improve satiety, and make eating patterns easier to manage

As adoption of drugs like Ozempic, Wegovy, and Mounjaro increases, eating patterns are shifting toward smaller portions, higher protein intake, and fiber-rich foods that support satiety

therefore, providing a better regime of shedding the extra mass as compared to that of GLP-1 agonists only

Wegovy (semaglutide) Summary of Product Characteristics (SmPC)